IDXX Latest Headlines

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV)

at www.tipranks.com (Thu, 5-Feb 2:30 AM)

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

at www.benzinga.com (Tue, 3-Feb 10:12 AM)

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST)

at www.tipranks.com (Tue, 3-Feb 9:03 AM)

Balanced Risk Profile and Slower Near-Term Margin Expansion Support Neutral Stance on Idexx Laboratories

at www.tipranks.com (Tue, 3-Feb 7:08 AM)

Idexx Laboratories: Strong Q4 Execution, Robust 2026 Outlook, and Expanding Diagnostics Platform Support Buy Rating

at www.tipranks.com (Mon, 2-Feb 9:26 PM)

Idexx Laboratories Earnings Call Highlights Resilient Growth

at www.tipranks.com (Mon, 2-Feb 7:04 PM)

Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?

at www.benzinga.com (Mon, 2-Feb 1:40 PM)

Idexx Laboratories: Recurring Diagnostics Strength, Innovation Pipeline, and Pet Health Tailwinds Support Buy Rating

at www.tipranks.com (Mon, 2-Feb 9:06 AM)

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY)

at www.tipranks.com (Mon, 2-Feb 9:03 AM)

Options Volatility and Implied Earnings Moves Today, February 02, 2026

at www.tipranks.com (Mon, 2-Feb 7:05 AM)

IDEXX Laboratories Non-GAAP EPS of $3.01 beats by $0.07, revenue of $1.09B beats by $20M

at seekingalpha.com (Mon, 2-Feb 6:32 AM)